Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Intensive care treatment may be bad for your health

12.08.2002


Two articles in the latest issue of Critical Care reveal how intensive care therapy may be beneficial in the short but not in the long term. Being treated in intensive care units may help critically ill patients survive but the quality of life - if they survive - is often severely impaired. It is unclear whether this impairment is a complication of the illness or a complication of therapy.



Many intensive care doctors believe the battle has been won once a patient leaves the intensive care unit, however Gordon Rubenfeld from the University of Washington in Seattle suggests that it is important to focus intensive care treatment on improving the long-term health of those who survive. Rubenfeld shows that doctors may face a conflict in deciding on treatments that are best at saving lives and those that give the best quality of life to those patients who survive. He stresses that more research is needed to make these decisions with confidence.

An example of research into how well or badly patients fare after they have left the intensive care unit is the study by Dale Rublee and colleagues. It examines the long-term effects of treating patients with sepsis with the drug antithrombin III. Antithrombin III affects the blood`s clotting mechanism and is a potential treatment for sepsis, a critical condition characterised by a combination of problems with the clotting mechanism and an inflammation throughout the body, which can lead to multiple organ failure and death.


The results of this study suggest that treatment with antithrombin III neither improves nor diminishes patients` chances of survival but it does leave patients with an improved quality of life 90 days after treatment. By focusing on the long-term effects of treatment Rublee and colleagues may have identified a treatment that will help improve the quality of patients` lives if they survive critical illness.

Quality of life was measured by looking at a range of factors such as the patients` mobility, their level of physical activity and their ability to communicate effectively. The study showed that improvements in social and psychological functioning were most marked in patients treated with antithrombin III.

Reducing the long-term impairment in health associated with critical illness represents a new challenge in medicine and it is hoped that clinical research will begin to focus on these issues.

###

The research article by Dale Rublee and colleagues is freely available in Critical Care, a journal published by BioMed Central, simply visit: http://ccforum.com/inpress/cc-6-4-rublee

The accompanying commentary by Gordon Rubenfeld can be found in the same issue of Critical Care, for access to this article visit: http://ccforum.com/info/media/press-releases/rubenfeld.pdf

Any articles published using the material featured in these articles should reference Critical Care, a journal published by BioMed Central.

Please contact Gordon Fletcher for further information, email - gordon@biomedcentral.com, phone - +44 (0) 20 7323 0323

Critical Care is a journal published by BioMed Central http://www.biomedcentral.com, an independent online publishing house committed to providing immediate free access to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science. In addition to open-access original research, BioMed Central also publishes reviews, abstracts and subscription-based content.

Gordon Fletcher | alfa
Further information:
http://ccforum.com/inpress/cc-6-4-rublee
http://ccforum.com/info/media/press-releases/rubenfeld.pdf

More articles from Health and Medicine:

nachricht Protein shapes matter in Alzheimer's research
20.05.2020 | Michigan Technological University

nachricht Genetic tradeoffs do not stop evolution of antibiotic resistance
19.05.2020 | Universität zu Köln

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

Im Focus: NASA's Curiosity rover finds clues to chilly ancient Mars buried in rocks

By studying the chemical elements on Mars today -- including carbon and oxygen -- scientists can work backwards to piece together the history of a planet that once had the conditions necessary to support life.

Weaving this story, element by element, from roughly 140 million miles (225 million kilometers) away is a painstaking process. But scientists aren't the type...

Im Focus: Making quantum 'waves' in ultrathin materials

Study co-led by Berkeley Lab reveals how wavelike plasmons could power up a new class of sensing and photochemical technologies at the nanoscale

Wavelike, collective oscillations of electrons known as "plasmons" are very important for determining the optical and electronic properties of metals.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

25.05.2020 | Medical Engineering

New gravitational-wave model can bring neutron stars into even sharper focus

22.05.2020 | Physics and Astronomy

A replaceable, more efficient filter for N95 masks

22.05.2020 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>